AChE |
acetylcholinesterase inhibitors |
AD |
Alzheimer’s disease |
BACE1 |
beta-Secretase 1 |
BBB |
blood–brain barrier |
BDNF |
brain-derived neurotrophic factor |
DOPE |
dioleylphosphatidylethanolamine |
FDA |
U.S. Food and Drug Administration |
Lf |
lactoferrin |
MAOIs |
monoamine oxidase inhibitors |
MEM |
memantine hydrochloride |
MRI |
magnetic resonance imaging |
NMDA |
N-methyl-d-aspartate |
NPs |
nanoparticles |
PEG |
polyethylene glycol |
PLA |
polylactide acid |
PLGA |
poly lactic-co-glycolic acid |
RES |
reticuloendothelial system |
SARIs |
serotonin antagonists and reuptake inhibitors |
SLNs |
solid lipid nanoparticles |
SNRIs |
serotonin and norepinephrine reuptake inhibitors |
SPIONs |
superparamagnetic iron oxide nanoparticles |
SSRIs |
selective serotonin reuptake inhibitors |
TCAs |
tricyclic antidepressants |